Spyre Therapeutics, Inc.Spyre Therapeutics, Inc.Spyre Therapeutics, Inc.

Spyre Therapeutics, Inc.

No trades
See on Supercharts

Price target

47.630.000.00%
The 8 analysts offering 1 year price forecasts for SYRE have a max estimate of — and a min estimate of —.

Analyst rating

Based on 9 analysts giving stock ratings to SYRE in the past 3 months.

EPS

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise

Revenue

‪0.00‬
Reported
Estimate
Reported
Estimate
Surprise
Be warned

Frequently Asked Questions


SYRE EPS for the last quarter is −1.36 USD despite the estimation of −0.82 USD. In the next quarter EPS is expected to reach −0.76 USD. Track more of Spyre Therapeutics, Inc. financials and stay on top of what is up with the company.
In the next quarter Spyre Therapeutics, Inc. revenue is expected to reach ‪4.20 M‬ USD. Check out Spyre Therapeutics, Inc. revenue and earnings and make informed decisions.
According to analysts, SYRE price target is 47.63 USD with a max estimate of 65.00 USD and a min estimate of 37.00 USD. Check if this forecast comes true in a year, meanwhile watch Spyre Therapeutics, Inc. stock price chart and keep track of the current situation with SYRE news and stock market news.
We've gathered opinions of 9 analysts rating SYRE stock in the past 3 months. Most of them backed up the strong buy trend, and after taking into account other opinions, the overall rating was calculated as strong buy. Note that it's not a trading advice — your own analysis is still required.